share_log

HC Wainwright & Co. Reiterates Buy on Omega Therapeutics, Maintains $11 Price Target

Benzinga ·  Sep 1, 2023 06:30

HC Wainwright & Co. analyst Robert Burns reiterates Omega Therapeutics (NASDAQ:OMGA) with a Buy and maintains $11 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment